What is Lifecore Biomedical, Inc.'s return on equity?

Lifecore Biomedical, Inc. (LFCR) reported return on equity of -612.1% in Q1 2025.

What is the long-term trend for Lifecore Biomedical, Inc.'s return on equity?

Over 2 years (2021 to 2025), Lifecore Biomedical, Inc.'s return on equity has grown at a 539.7% compound annual growth rate (CAGR), from -15% to -612.1%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Lifecore Biomedical, Inc. LFCR Return on equity

Return on equity at other companies

Baxter InternationalBAX

-16.7%-76.7pp

Thermo Fisher ScientificTMO

13.5%-0.2pp

ADMA BiologicsADMA

43.3%-35.2pp

Medpace Holdings, Inc.MEDP

77.3%+11.4pp

Biodesix, Inc.BDSX

-316.5%—

ClearPoint NeuroCLPT

-149.7%+4,074pp

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

net income/total stockholders equity=-612.1%

Based on trailing twelve months.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s return on equity?: Lifecore Biomedical, Inc. (LFCR) reported return on equity of -612.1% in Q1 2025.
What is the long-term trend for Lifecore Biomedical, Inc.'s return on equity?: Over 2 years (2021 to 2025), Lifecore Biomedical, Inc.'s return on equity has grown at a 539.7% compound annual growth rate (CAGR), from -15% to -612.1%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.